RLAY
Relay Therapeutics Inc

1,074
Loading...
Loading...
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
261

Frequently Asked Questions

What is Market Cap of Relay Therapeutics Inc?
What is the 52-week high for Relay Therapeutics Inc?
What is the 52-week low for Relay Therapeutics Inc?
What is Relay Therapeutics Inc stock price today?
What was Relay Therapeutics Inc stock price yesterday?
What is the PE ratio of Relay Therapeutics Inc?
What is the Price-to-Book ratio of Relay Therapeutics Inc?
What is the 50-day moving average of Relay Therapeutics Inc?
How many employess does Relay Therapeutics Inc has?

Latest RLAY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.